ARYNTA 10 mg/mL
lisdexamfetamine dimesylate oral · SOLUTION · Azurity Pharmaceuticals, Inc.
ARYNTA is a solution containing lisdexamfetamine dimesylate oral at 10 mg/mL, taken oral. Manufactured by Azurity Pharmaceuticals, Inc..
Key Facts
- Brand Name
- ARYNTA
- Generic Name
- lisdexamfetamine dimesylate oral
- NDC Code (Product)
24338-103- Manufacturer
- Azurity Pharmaceuticals, Inc.
- Strength
- 10 mg/mL
- Dosage Form
- SOLUTION
- Route
- ORAL
- Marketing Status
- DEA Schedule
- Schedule II (Controlled)
- Application #
- NDA219847
- Marketing Start
- 03/20/2026
Recall History
No Recall HistoryFrequently Asked Questions
What is ARYNTA used for?
ARYNTA contains lisdexamfetamine dimesylate oral. It is a solution taken oral. Consult your doctor for specific uses.
Is ARYNTA a controlled substance?
Yes, ARYNTA is classified as CII under the DEA Controlled Substances Act.
What is the generic name for ARYNTA?
The generic name for ARYNTA is lisdexamfetamine dimesylate oral. There are no other listed brand versions of lisdexamfetamine dimesylate oral.
What is the NDC code for ARYNTA 10 mg/mL?
The NDC (National Drug Code) for ARYNTA 10 mg/mL is 24338-103, listed by Azurity Pharmaceuticals, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)